Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies
Clinical Trial Grant
Duke Scholars
Principal Investigator
April Kelly Scott Salama
Medicine, Medical Oncology
Awarded By
Seattle Genetics, Inc
Start Date
July 23, 2021
End Date
March 4, 2025
Awarded By
Seattle Genetics, Inc
Start Date
July 23, 2021
End Date
March 4, 2025
